Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,126,661
+$1,240,550 QoQ
Shares Held
20,373
+14.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#1,293
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $24,225,985 across 10 Drug Manufacturers - General names. ABBV ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,836 | $7,577,448 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
20,373 | $5,126,661 | |
| 3 | LLY |
ELI LILLY & Co
|
4,139 | $4,964,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,514 | $3,407,049 | |
| 5 | PFE |
Pfizer Inc
|
31,586 | $760,590 | |
| 6 | AMGN |
Amgen Inc
|
1,749 | $633,347 | |
| 7 | NVS |
Novartis AG
|
3,412 | $534,728 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,910 | $493,989 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,126,661 | 20,373 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,886,111 | 17,868 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,416,026 | 19,327 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,144,566 | 17,900 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,198,975 | 17,234 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,018,593 | 19,180 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $3,709,859 | 18,786 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,249,274 | 18,944 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,492,678 | 19,180 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $2,466,657 | 15,917 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,305,361 | 15,466 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,026,608 | 15,042 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,454,457 | 15,401 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,381,969 | 14,739 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,989,260 | 14,822 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,543,950 | 29,668 | Shares | Sole | 2022-09-20 | |
| 2022-03-31 | $2,567,336 | 15,837 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,179,127 | 16,094 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,550,523 | 14,374 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,251,708 | 37,746 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,620,594 | 14,975 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,686,219 | 15,737 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,420,884 | 16,222 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,587,276 | 16,167 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,263,077 | 16,578 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||